FDA approves first pill to prevent recurrent C. difficile infections聽
The Food and Drug Administration the first fecal microbiota product taken orally to prevent recurrent C. difficile infection.
鈥淭oday鈥檚 approval provides patients and healthcare providers a new way to help prevent recurrent C. difficile infection,鈥 Peter Marks, M.D., director of the FDA鈥檚 Center for Biologics Evaluation and Research. 鈥淭he availability of a fecal microbiota product that can be taken orally is a significant step forward in advancing patient care and accessibility for individuals who have experienced this disease that can be potentially life-threatening.鈥
Related News Articles
Headline
Though seasonal flu activity is low or minimal across the country, 216 pediatric deaths associated with seasonal influenza virus infection have been tallied so鈥
Headline
The U.S. has had 935 confirmed cases of measles so far this year, according to the latest data from the Centers for Disease Control and Prevention. Cases have鈥
Headline
There have been 884 confirmed cases of measles nationwide so far this year, with cases reported by 29 states, according to the latest data from the鈥
Headline
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and鈥
Headline
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections鈥
Headline
The Centers for Disease Control and Prevention April 18 announced there have been 800 reported cases of measles across the country this year. Twenty-four鈥